PE20051138A1 - BLOQUEADORES DE Kv1.5 REFERIDOS AL AUMENTO SELECTIVO DE LA CONTRACTILIDAD - Google Patents

BLOQUEADORES DE Kv1.5 REFERIDOS AL AUMENTO SELECTIVO DE LA CONTRACTILIDAD

Info

Publication number
PE20051138A1
PE20051138A1 PE2005000178A PE2005000178A PE20051138A1 PE 20051138 A1 PE20051138 A1 PE 20051138A1 PE 2005000178 A PE2005000178 A PE 2005000178A PE 2005000178 A PE2005000178 A PE 2005000178A PE 20051138 A1 PE20051138 A1 PE 20051138A1
Authority
PE
Peru
Prior art keywords
referred
alkyl
compounds
phenyl
contractility
Prior art date
Application number
PE2005000178A
Other languages
English (en)
Inventor
Klaus Wirth
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PE20051138A1 publication Critical patent/PE20051138A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

REFERIDA A COMPUESTOS DE FORMULA Ia Y/O Ib R1 ES ALQUILO C3-C5, QUINOLINILO; R2 ES ALQUILO C1-C4, CICLOPROPILO; R3 ES FENILO, PIRIDILO; A ES -CnH2n-; n ES 1, 2; R4, R5, R6 Y R7 SON CADA UNO H, F, CF3, ENTRE OTROS; B ES -CmH2m-; m ES 1, 2; R8 ES ALQUILO C2-C3, FENILO, PIRIDILO SUSTITUIDOS O NO; R9 ES COOR10, COR10; R10 ES -CxH2x-R11; x ES 1, 2; R11 ES FENILO SUSTITUIDO O NO. DICHOS COMPUESTOS SE PUEDEN SELECCIONAR DE: N-(2-PIRIDIN-3-ILETIL)-2'-{[2-(4-METOXIFENIL)ACETILAMINO]METIL}BIFENIL-2-CARBOXAMIDA; 2-(BUTIL-1-SULFONILAMINO)-N-[1(R)-(6-METOXIPIRIDIN-3-ILMETIL)PROPIL]BENZAMIDA Y (S)-5-FLUORO-2-(QUINOLINA-8-SULFONILAMINO)-N-(1-FENILPROPIL)BENZAMIDA; ENTRE OTROS. TAMBIEN REFERIDA AL USO DE ESTOS COMPUESTOS O UNA DE SUS SALES PARA PRODUCIR UN MEDICAMENTO PARA LA PROFILAXIS O TERAPIA DE LA INSUFICIENCIA CARDICA DIASTOLICA
PE2005000178A 2004-02-26 2005-02-15 BLOQUEADORES DE Kv1.5 REFERIDOS AL AUMENTO SELECTIVO DE LA CONTRACTILIDAD PE20051138A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004009931A DE102004009931A1 (de) 2004-02-26 2004-02-26 Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz

Publications (1)

Publication Number Publication Date
PE20051138A1 true PE20051138A1 (es) 2006-02-06

Family

ID=34853866

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000178A PE20051138A1 (es) 2004-02-26 2005-02-15 BLOQUEADORES DE Kv1.5 REFERIDOS AL AUMENTO SELECTIVO DE LA CONTRACTILIDAD

Country Status (15)

Country Link
US (1) US20070043091A1 (es)
EP (1) EP1720549A1 (es)
JP (1) JP2007523926A (es)
KR (1) KR20060125862A (es)
CN (1) CN1921855A (es)
AR (1) AR047975A1 (es)
AU (1) AU2005218731A1 (es)
BR (1) BRPI0508054A (es)
CA (1) CA2557263A1 (es)
DE (1) DE102004009931A1 (es)
IL (1) IL177255A0 (es)
PE (1) PE20051138A1 (es)
TW (1) TW200536522A (es)
UY (1) UY28777A1 (es)
WO (1) WO2005084675A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2586208A1 (en) * 2004-11-22 2006-09-08 Integragen Human obesity susceptibility gene encoding potassium ion channels and uses thereof
WO2007124849A2 (en) * 2006-04-27 2007-11-08 Sanofi-Aventis Deutschland Gmbh Inhibitors of the task-1 and task-3 ion channel
CN105254557A (zh) 2009-05-29 2016-01-20 拉夸里亚创药株式会社 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
WO2010139585A2 (en) * 2009-06-03 2010-12-09 Sanofi-Aventis Deutschland Gmbh Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide
CN107033064B (zh) * 2017-04-28 2019-07-09 西安医学院 一种3-(吗啉取代芳亚胺基)吲哚类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100189863B1 (ko) * 1993-12-27 1999-06-01 나이또 하루오 안트라닐산 유도체
US5935945A (en) * 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
HU228111B1 (en) * 1998-07-08 2012-11-28 Sanofi Aventis Deutschland Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
US6531495B1 (en) * 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE19947457A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
DE10060809A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121002A1 (de) * 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) * 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE10312073A1 (de) * 2003-03-18 2004-09-30 Aventis Pharma Deutschland Gmbh 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
AU2005218731A1 (en) 2005-09-15
KR20060125862A (ko) 2006-12-06
IL177255A0 (en) 2006-12-10
DE102004009931A1 (de) 2005-09-15
UY28777A1 (es) 2005-09-30
JP2007523926A (ja) 2007-08-23
AR047975A1 (es) 2006-03-15
WO2005084675A1 (de) 2005-09-15
CN1921855A (zh) 2007-02-28
EP1720549A1 (de) 2006-11-15
CA2557263A1 (en) 2005-09-15
US20070043091A1 (en) 2007-02-22
BRPI0508054A (pt) 2007-07-17
TW200536522A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
AR049110A1 (es) Compuestos terapeuticos: piridina como andamiaje estructural
RU2423354C2 (ru) Соединения и композиции - модуляторы сигнального пути hedgehog
PE20030968A1 (es) Derivados de 5-feniltiazol como inhibidores de cinasas
PE20090641A1 (es) Amidas heterociclicas
PE20080061A1 (es) Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
PE20070829A1 (es) Inhibidores cetp heterociclicos
PE20060693A1 (es) Nuevos derivados de trifluorometansulfonanilida oxamida eter
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
BRPI0507506A (pt) compostos
PE20141375A1 (es) Activadores de glucoquinasa
NZ616298A (en) Aryl-or heteroaryl-substituted benzene compounds
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
WO2004013101A3 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
MEP22008A (en) Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
PE20120136A1 (es) Compuestos derivados de n-acilsulfonamidas como inhibidores de bcl-2
PE20071034A1 (es) Compuestos heterociclicos como inhibidores de cetp
PT998473E (pt) Modificacao da forma de cristal de um derivado de n-fenil-2-pirimidinoamina processos para a sua preparacao e sua utilizacao
PE20050132A1 (es) Piperazinas heterociclicas sustituidas
PE20051138A1 (es) BLOQUEADORES DE Kv1.5 REFERIDOS AL AUMENTO SELECTIVO DE LA CONTRACTILIDAD
PE20061163A1 (es) Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos
AR062299A1 (es) Derivados de bencimidazol
PE20011089A1 (es) Tioamidas de oxazolidinona con sustituyentes de piperazin-amida
AR049995A1 (es) Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida
DK0821682T3 (da) Benzimidazolforbindelser og deres anvendelse som modulatorer af gaba-a-receptorkomplekset

Legal Events

Date Code Title Description
FA Abandonment or withdrawal